The burden of blood-pressure-related cardiovascular mortality in Mexico
- PMID: 24678416
- PMCID: PMC3941157
- DOI: 10.1155/2014/427684
The burden of blood-pressure-related cardiovascular mortality in Mexico
Abstract
This study shows that in Mexico, a country at an advanced stage in the epidemiologic transition, with the national burden of disease dominated by noncommunicable diseases, elevated blood pressure is a major clinical and public health problem. 31.7% of the Mexican individuals aged 50 and over had systolic hypertension, and 47.3% were at systolic prehypertensive levels. Also, approximately half of all cardiovascular deaths that occurred annually in the population of Mexico aged ≥50 years are attributable to above optimal levels of systolic blood pressure. We think these estimates may help order health priorities in Mexico (and other middle-income countries) at a time when the costs of medical care take a considerable share of the gross national product in most countries.
Figures

Similar articles
-
Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors.PLoS Med. 2008 Jun 17;5(6):e125. doi: 10.1371/journal.pmed.0050125. PLoS Med. 2008. PMID: 18563960 Free PMC article.
-
The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study.Lancet Public Health. 2022 Dec;7(12):e1027-e1040. doi: 10.1016/S2468-2667(22)00232-8. Lancet Public Health. 2022. PMID: 36462514
-
The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.Lancet Glob Health. 2020 Oct;8(10):e1282-e1294. doi: 10.1016/S2214-109X(20)30311-9. Lancet Glob Health. 2020. PMID: 32971051
-
Global burden of blood-pressure-related disease, 2001.Lancet. 2008 May 3;371(9623):1513-8. doi: 10.1016/S0140-6736(08)60655-8. Lancet. 2008. PMID: 18456100 Review.
-
Cardiovascular diseases in mega-countries: the challenges of the nutrition, physical activity and epidemiologic transitions, and the double burden of disease.Curr Opin Lipidol. 2016 Aug;27(4):329-44. doi: 10.1097/MOL.0000000000000320. Curr Opin Lipidol. 2016. PMID: 27389629 Free PMC article. Review.
Cited by
-
Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome.Curr Hypertens Rep. 2022 Sep;24(9):325-340. doi: 10.1007/s11906-022-01194-5. Epub 2022 Jun 15. Curr Hypertens Rep. 2022. PMID: 35704140 Free PMC article. Review.
-
Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism.Genes Nutr. 2014 Sep;9(5):421. doi: 10.1007/s12263-014-0421-7. Epub 2014 Aug 9. Genes Nutr. 2014. PMID: 25106483 Free PMC article.
References
-
- Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet. 2002;360(9349):1903–1913. - PubMed
-
- Kannel WB. Update on hypertension as a cardiovascular risk factor. In: Mancia G, Chalmers J, Julius S, et al., editors. Manual of Hypertension. London, UK: Churchill Livingstone; 2002. pp. 3–21.
-
- Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation atudy investigators. The New England Journal of Medicine. 2000;342:145–153. - PubMed
-
- Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension. 2005;45(5):907–913. - PubMed
-
- Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. New England Journal of Medicine. 2008;358(18):1887–1898. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources